Polymer-grafted hollow mesoporous silica nanoparticles integrated with microneedle patches for glucose-responsive drug delivery

• Published in: Frontiers of materials science Vol. 15; no. 1; pp. 98 - 112
• Main Authors: WANG, Yaping, CHENG, Songyue, HU, Wei, LIN, Xue, CAO, Cong, ZOU, Shufen, TONG, Zaizai, JIANG, Guohua, KONG, Xiangdong
• Format: Journal Article
• Language: English
• Published: Beijing Higher Education Press 01.03.2021
• Subjects: Chemistry and Materials Science; diabetes; glucose-responsive release; hollow mesoporous silica nanoparticles; Materials Science; microneedles; Research Article; transdermal delivery; microneedles; transdermal delivery; diabetes; glucose-responsive release; hollow mesoporous silica nanoparticles
• ISSN: 2095-025X; 2095-0268
• DOI: 10.1007/s11706-021-0532-1

A glucose-mediated drug delivery system would be highly satisfactory for diabetes diagnosis since it can intelligently release drug based on blood glucose levels. Herein, a glucose-responsive drug delivery system by integrating glucose-responsive poly(3-acrylamidophenylboronic acid) (PAPBA) functionalized hollow mesoporous silica nanoparticles (HMSNs) with transcutaneous microneedles (MNs) has been designed. The grafted PAPBA serves as gatekeeper to prevent drug release from HMSNs at normoglycemic levels. In contrast, faster drug release is detected at a typical hyperglycemic level, which is due to the change of hydrophilicity of PAPBA at high glucose concentration. After transdermal administration to diabetic rats, an effective hypoglycemic effect is achieved compared with that of subcutaneous injection. These observations indicate that the designed glucose-responsive drug delivery system has a potential application in diabetes treatment.